An Image-based Screen Identifies a Small Molecule Regulator of Megakaryopoiesis
Overview
Affiliations
Molecules that control the lineage commitment of hematopoietic stem cells (HSCs) may allow the expansion of enriched progenitor populations for both research and therapeutic uses. In an effort to better understand and control the differentiation of HSCs to megakaryocytes, we carried out an image-based screen of a library of 50,000 heterocycles using primary human CD34(+) cells. A class of naphthyridinone derivatives was identified that induces the differentiation of common myeloid progenitors (CMP) to megakaryocytes. Kinase profiling and subsequent functional assays revealed that these compounds act through inhibition of platelet-derived growth factor receptor (PDGFR) signaling in CMPs. Such molecules may ultimately have clinical utility in the treatment of thrombocytopenia.
Lee K, Ahn H, Estevez B, Poncz M Blood. 2022; 141(3):260-270.
PMID: 36219879 PMC: 9936297. DOI: 10.1182/blood.2022017561.
Zhu F, Feng M, Sinha R, Murphy M, Luo F, Kao K Proc Natl Acad Sci U S A. 2019; 116(37):18416-18422.
PMID: 31451629 PMC: 6744911. DOI: 10.1073/pnas.1906251116.
Joslin J, Gilligan J, Anderson P, Garcia C, Sharif O, Hampton J SLAS Discov. 2018; 23(7):697-707.
PMID: 29843542 PMC: 6055113. DOI: 10.1177/2472555218773086.
Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells.
Aihara A, Koike T, Abe N, Nakamura S, Sawaguchi A, Nakamura T Blood Adv. 2018; 1(7):468-476.
PMID: 29296963 PMC: 5738977. DOI: 10.1182/bloodadvances.2016000844.
Human is a key target of RUNX1 in megakaryocytic differentiation.
Li Y, Jin C, Bai H, Gao Y, Sun S, Chen L Blood. 2017; 131(2):191-201.
PMID: 29101237 PMC: 5757696. DOI: 10.1182/blood-2017-04-780379.